Health knowledge made personal
Join this community!
› Share page:
Go
Search posts:

research: RANKL’s role in cancer metastasis

Posted Feb 18 2011 12:00am

The new drug that I am taking, Xgeva© (denosumab), to help control skeletal related events (SRE) of bone metastases, acts by suppressing the activity of a protein called RANKL. My previous post dated October 21, 2010, briefly describes the way … Continue reading

Post a comment
Write a comment: